News and Announcements
The West Winds Gin Capital Raising Update
- Published November 10, 2014 1:39PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
The Tailor Made Spirits Company Limited Board has elected to extend the closing date for the current capital raising until the 30th of November 2014.
As of the 31st of October the Company had received a combination of committed funds and expressions of interest that the company believe indicate that they will be successful in closing their capital raising at a figure above their stated minimum of $400,000 by the extended date.
Through the capital raising process, the Board has been put in contact with 3 separate parties that may provide options for securing non-dilutive debt finance rather than equity. Paul White, the CEO of the company, says: “We are obtaining more information and terms around these options to determine if this is a viable option. We intend to complete this evaluation during November in line with our extended capital raise timeline”.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
